Recurrent optic neuritis as early presentation of idiopathic hypertrophic cranial pachymeningitis

Norhayaty Samsudin, Evelyn Li Min Tai, Chui Yain Chen, Lakana Kumar Tharavatnam, Azhany Yaakub, Adil Hussein, Win Mar Salmah, John Tharakan, Wan-Hazabbah Wan Hitam, Sim See Khim

Abstract


A 44-year-old Malay lady presented with drooping of the right eyelid and worsening of left eye vision for one week duration. There was associated headache, periorbital discomfort and diplopia on left gaze. She previously had a history of recurrent optic neuritis affecting both eyes over a period of 12 years. On examination, there was right-sided partial ptosis and left exotropia. The adduction, abduction, elevation and depression of the right eye was limited. Left eye extraocular movements were full. The right eye visual acuity was 6/9, while the left eye visual acuity was perception to light, with a positive relative afferent papillary defect and a pale optic disc. The right optic disc was normal. There was reduced sensation in the trigeminal nerve distribution over the right side of the face. Neurological examination was otherwise normal. Magnetic resonance imaging of the brain and orbit revealed meningeal thickening with involvement of the right orbital apex and cavernous sinus. Blood investigations for infectious and autoimmune causes were unremarkable. She was diagnosed to have idiopathic hypertrophic cranial pachymeningitis and treated with systemic corticosteroids. The right eye extraocular motility improved, while the left eye visual acuity improved to counting finger. This case demonstrates that idiopathic hypertrophic cranial pachymeningitis may present as recurrent optic neuritis in the early phase, before radiological evidence of the disease is present. A high index of suspicion for the underlying cause is essential to prevent irreversible optic nerve damage due to recurrent optic neuritis.

Keywords


Hypertrophic pachymeningitis, optic neuritis, ophthalmoplegia

Full Text:

PDF

References


Mamelak AN, Kelly WM, Davis RL, Rosenblum ML. Idiopathic hypertrophic cranial pachymeningitis. Report of three cases. J Neurosurg. 1993; 79(2):pp270-276.

Hamilton SR, Smith CH, Lessell S. Idiopathic hypertrophic cranial pachymeningitis. J Clin Neuro Ophthalmol. 1993; 13(2):pp127-134.

Hosler MR, Turbin RE, Cho ES, Wolansky LJ, Frohman LP. Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma. J Neuroophthalmol . 2007; 27(2):pp95-98.

Beck RW, Cleary PA, Anderson MM, Jr., Keltner JL, Shults WT, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992; 326(9):pp581-588.

Lee YC, Chueng YC, Hsu SW, Lui CC. Idiopathic hypertrophic cranial pachymeningitis: case report with 7 years of imaging follow-up. AJNR Am J Neuroradiol. 2003; 24(1):pp119-123.

Rossi S, Giannini F, Cerase A, Bartalini S, Tripodi S, et al. Uncommon findings in idiopathic hypertrophic cranial pachymeningitis. J. Neurol. 2004; 251(5):pp548-555.

Riku S, Kato S. Idiopathic hypertrophic pachymeningitis. Neuropathology. 2003; 23(4):pp335-344.

Yokoseki A, Saji E, Arakawa M, Kosaka T, Hokari M, Toyoshima Y, Okamoto K, Takeda S, Sanpei K, Kikuchi H, Hirohata S. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain. 2014; 137(2):pp520-536.

Dumont AS, Clark AW, Sevick RJ, Myles ST. Idiopathic hypertrophic pachymeningitis: a report of two patients and review of the literature. Can. J. Neurol. Sci. 2000; 27(4):pp333-340.




Copyright (c) 2017 Journal of Biomedical and Clinical Sciences (JBCS)



 

Flag Counter           

                     

                                              Copyright © 2016 AMDI Publisher, Universiti Sains Malaysia.
Disclaimer : This website has been updated to the best of our knowledge to be accurate. However, Universiti Sains Malaysia shall not be liable for any loss or damage caused by the usage of any information obtained from this web site.
                                            Best viewed: Mozilla Firefox 4.0 & Google Chrome at 1024 × 768 resolution.